But he remains optimistic about the promise of these drugs to reduce the risk of some cancers and believes the issue calls for further study
So far, studies have reported: Phase 2 (48 weeks): up to 24.2% average weight loss Phase 3 TRIUMPH-4 topline (68 weeks): 28.7% average weight loss (press release) What that looks like: If you start at 100 kg : 24.2% 24 kg average loss 28.7% 29 kg average loss Side effects and safety signals (what we know so far) Phase 2 (peer-reviewed) In the phase 2 trial, the most common adverse events were gastrointestinal and dose-related, typically mild to moderate
PlexusDx offers the test at $298 standalone or $99 as an add-on after your first month on any protocol, payable by HSA/FSA card where your plan accepts diagnostic-test documentation
Download on the App Store
68 weeks (aggressive) 9-12 x 10 mg vials Maintenance at 12 mg weekly
We can review your diabetes management, help you navigate coverage options, counsel you on injection technique, and coordinate with your physician to ensure your care is seamless